title: Sources of heterogeneity in human monocyte subsets.
abstract: Human monocytes are commonly defined and discriminated by the extent of their cell surface expression of CD14 and CD16, with associated differences in function and phenotype related to the intensity of expression of these markers. With increasing interest into the function and behaviour of monocytes, it is important to have a clear understanding of how differing strategies of analysis can affect results and how different protocols and population backgrounds can affect this highly morphogenic cell type. Using PBMCs from populations with differing ethnicities and histories of parasite exposure we have characterized monocyte phenotype based on intensity of CD14 and CD16 expression. Using the surface markers HLA-DR, CCR2 and CX3CR1, we compared monocyte phenotype between populations and further assessed changes in monocytes with freezing and thawing of PBMCs. Our results reveal that there is a progression of surface marker expression based on intensity of CD14 or CD16 expression, stressing the importance of careful gating of monocyte subtypes. Freezing and thawing of the PBMCs has no effect generally on the monocytes, although it does lead to a decrease in CD16 and CX3CR1 expression. We show that there are differences in the monocyte populations based on ethnicity and history of exposure to the common parasites Plasmodium falciparum and Schistosoma haematobium. This study highlights that blood monocytes consist of a continuous population of cells, within which the dominant phenotype may vary dependent on the background of the study population. Comparing results from monocyte studies therefore needs to be done with great care, as ethnic background of donor population, gating strategy and processing of PBMCs may all have an effect on outcome of monocyte phenotype.
authors.affiliation: Institute for Immunology & Infection Research, Centre for Immunity, Infection & Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh, UK. l.j.appleby@sms.ed.ac.uk
authors.forename: Laura J
authors.initials: LJ
authors.lastname: Appleby
authors.forename: Norman
authors.initials: N
authors.lastname: Nausch
authors.forename: Nicholas
authors.initials: N
authors.lastname: Midzi
authors.forename: Takafira
authors.initials: T
authors.lastname: Mduluza
authors.forename: Judith E
authors.initials: JE
authors.lastname: Allen
authors.forename: Francisca
authors.initials: F
authors.lastname: Mutapi
mesh_terms: D000293:Adolescent; D000328:Adult; D000349:Africa; D000073883:CX3C Chemokine Receptor 1; D002648:Child; D015925:Cryopreservation; D005006:Ethnicity; D005060:Europe; D005260:Female; D006684:HLA-DR Antigens / Q000378:metabolism; D006801:Humans; D016130:Immunophenotyping; D018950:Lipopolysaccharide Receptors / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology*; D054390:Receptors, CCR2 / Q000378:metabolism; D019707:Receptors, Chemokine / Q000378:metabolism; D017452:Receptors, IgG / Q000378:metabolism; D012424:Rural Population; D014505:Urban Population; D055815:Young Adult
chemical_list: C515334:CCR2 protein, human; D000073883:CX3C Chemokine Receptor 1; C095235:CX3CR1 protein, human; D006684:HLA-DR Antigens; D018950:Lipopolysaccharide Receptors; D054390:Receptors, CCR2; D019707:Receptors, Chemokine; D017452:Receptors, IgG
references.citation: Cytometry A. 2010 Sep;77(9):823-30
references.pmid: 20662093
references.citation: Immunity. 2013 Jan 24;38(1):79-91
references.pmid: 23273845
references.citation: J Biomed Biotechnol. 2010;2010:262609
references.pmid: 20145705
references.citation: Trans R Soc Trop Med Hyg. 2008 Oct;102(10):1039-45
references.pmid: 18656215
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2426-31
references.pmid: 12606720
references.citation: Blood. 2010 Oct 21;116(16):e74-80
references.pmid: 20628149
references.citation: J Immunol Methods. 2003 Jul;278(1-2):145-55
references.pmid: 12957403
references.citation: Mem Inst Oswaldo Cruz. 2007 Jun;102(3):405-9
references.pmid: 17568947
references.citation: Cytometry A. 2012 Oct;81(10):823-34
references.pmid: 22837127
references.citation: Parasitology. 2011 Oct;138(12):1519-33
references.pmid: 21813042
references.citation: PLoS One. 2011 May 06;6(5):e19149
references.pmid: 21573157
references.citation: Clin Exp Immunol. 1995 May;100(2):314-8
references.pmid: 7538057
references.citation: PLoS One. 2011 Mar 01;6(3):e17484
references.pmid: 21390263
references.citation: Clin Diagn Lab Immunol. 2000 May;7(3):352-9
references.pmid: 10799445
references.citation: Rev Inst Med Trop Sao Paulo. 1972 Nov-Dec;14(6):397-400
references.pmid: 4675644
references.citation: Cancer Immunol Immunother. 1996 Dec;43(4):206-12
references.pmid: 9003465
references.citation: Bull Soc Pathol Exot Filiales. 1983 Jan-Feb;76(1):101-4
references.pmid: 6839402
references.citation: Annu Rev Genomics Hum Genet. 2008;9:403-33
references.pmid: 18593304
references.citation: Annu Rev Immunol. 2008;26:421-52
references.pmid: 18303997
references.citation: Immunobiology. 2009;214(9-10):737-47
references.pmid: 19577324
references.citation: J Natl Cancer Inst. 1990 Apr 18;82(8):697-703
references.pmid: 2138680
references.citation: Immunol Today. 1996 Sep;17(9):424-8
references.pmid: 8854561
references.citation: Science. 2010 Feb 5;327(5966):656-61
references.pmid: 20133564
references.citation: Blood. 2000 Jul 1;96(1):218-23
references.pmid: 10891454
references.citation: Am J Trop Med Hyg. 1988 Aug;39(2):150-6
references.pmid: 3044153
references.citation: Arthritis Res Ther. 2010;12(1):R14
references.pmid: 20102624
references.citation: Blood. 1989 Nov 15;74(7):2527-34
references.pmid: 2478233
references.citation: J Leukoc Biol. 2012 Jun;91(6):977-89
references.pmid: 22427683
references.citation: Results Immunol. 2011 Aug 22;1(1):36-44
references.pmid: 24371551
references.citation: J Thromb Haemost. 2011 May;9(5):1056-66
references.pmid: 21342432
references.citation: Cytometry A. 2007 Nov;71(11):934-44
references.pmid: 17879238
references.citation: Blood. 2011 Aug 4;118(5):e16-31
references.pmid: 21653326
references.citation: Immunol Res. 2012 Sep;53(1-3):41-57
references.pmid: 22430559
references.citation: BMC Immunol. 2006 May 25;7:11
references.pmid: 16725038
references.citation: J Cardiovasc Transl Res. 2011 Apr;4(2):211-9
references.pmid: 21308491
references.citation: BMC Genomics. 2009 Aug 27;10:403
references.pmid: 19712453
references.citation: Int Arch Allergy Immunol. 2012;158(3):288-98
references.pmid: 22398631
references.citation: Int J Med Sci. 2004;1(3):126-136
references.pmid: 15912191
references.citation: J Leukoc Biol. 2007 Mar;81(3):584-92
references.pmid: 17135573
references.citation: J Proteome Res. 2009 Aug;8(8):4028-38
references.pmid: 19514703
references.citation: PLoS One. 2012;7(1):e28918
references.pmid: 22235253
references.citation: Annu Rev Immunol. 2009;27:669-92
references.pmid: 19132917
references.citation: Science. 2007 Aug 3;317(5838):666-70
references.pmid: 17673663
references.citation: Nat Rev Immunol. 2005 Dec;5(12):953-64
references.pmid: 16322748
references.citation: Blood. 2011 Sep 22;118(12):e50-61
references.pmid: 21803849
references.citation: J Biol. 2009;8(11):99
references.pmid: 20067595